{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:45:30Z","timestamp":1773053130279,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["289499"],"award-info":[{"award-number":["289499"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pituitary adenomas (PA) are the second most common intracranial tumors and are classified according to hormone they produce, and the transcription factors they express. The majority of PA occur sporadically, and their molecular pathogenesis is incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here we performed transcriptome and proteome analysis of tumors derived from POU1F1 (GH-, TSH-, and PRL-tumors, N\u2009=\u200916), NR5A1 (gonadotropes and null cells adenomas, n\u2009=\u200917) and TBX19 (ACTH-tumors, n\u2009=\u20096) lineages as well as from silent ACTH-tumors (n\u2009=\u20093) to determine expression of kinases, cyclins, CDKs and CDK inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression profiles of genes encoding kinases were distinctive for each of the three PA lineage: NR5A1-derived tumors showed upregulation of ETNK2 and PIK3C2G and alterations in MAPK, ErbB and RAS signaling, POU1F1-derived adenomas showed upregulation of PIP5K1B and NEK10 and alterations in phosphatidylinositol, insulin and phospholipase D signaling pathways and TBX19-derived adenomas showed upregulation of MERTK and STK17B and alterations in VEGFA-VEGFR, EGF-EGFR and Insulin signaling pathways. In contrast, the expression of the different genes encoding cyclins, CDK and CDK inhibitors among NR5A1-, POU1F1- and TBX19-adenomas showed only subtle differences. CDK9 and CDK18 were upregulated in NR5A1-adenomas, whereas CDK4 and CDK7 were upregulated in POUF1-adenomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The kinome of PA clusters these lesions into three distinct groups according to the transcription factor that drives their terminal differentiation. And these complexes could be harnessed as molecular therapy targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-022-01206-y","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:02:37Z","timestamp":1646726557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages"],"prefix":"10.1186","volume":"15","author":[{"given":"Keiko","family":"Taniguchi-Ponciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesly A.","family":"Portocarrero-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Guinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Moreno-Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Gomez-Apo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Chavez-Macias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Pe\u00f1a-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Silva-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Vela-Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Ordo\u00f1ez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Andonegui-Elguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Ferreira-Hermosillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ramirez-Renteria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etual","family":"Espinosa-Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Laura","family":"Espinosa-de-los-Monteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latife","family":"Salame-Khouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blas","family":"Lopez-Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Vargas-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baldomero","family":"Gonzalez-Virla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Lisbona-Buzali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Marrero-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mois\u00e9s","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"1206_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2014.181","volume":"11","author":"A Lecoq","year":"2015","unstructured":"Lecoq A, Kamenick\u00fd P, Guiochon-Mantel A, Chanson P. Genetic mutations in sporadic pituitary adenomas\u2013what to screen for? Nat Rev Endocrinol. 2015;11:43\u201354.","journal-title":"Nat Rev Endocrinol"},{"key":"1206_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3803\/EnM.2020.35.2.237","volume":"35","author":"S Chin","year":"2020","unstructured":"Chin S. Epidemiology of functioning pituitary adenomas. Endocrinol Metab (Seoul). 2020;35:37\u2013242.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1206_CR3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"M Molitch","year":"2017","unstructured":"Molitch M. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516\u201324.","journal-title":"JAMA"},{"key":"1206_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10014-017-0307-7","volume":"35","author":"H Nishioka","year":"2018","unstructured":"Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol. 2018;35:57\u201361.","journal-title":"Brain Tumor Pathol"},{"key":"1206_CR5","doi-asserted-by":"crossref","first-page":"10503","DOI":"10.1038\/s41598-019-46385-4","volume":"9","author":"N Sugiyama","year":"2019","unstructured":"Sugiyama N, Imamura H, Ishihama Y. Large-scale discovery of substrates of the human kinome. Sci Rep. 2019;9:10503.","journal-title":"Sci Rep"},{"key":"1206_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc.2015.18","volume":"16","author":"E Fleuren","year":"2016","unstructured":"Fleuren E, Zhang L, Wu J, Daly R. The kinome \u201cat large\u201d in cancer. Nat Rev Cancer. 2016;16:83\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1206_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1507\/endocrj.EJ21-0106","volume":"68","author":"C Liu","year":"2021","unstructured":"Liu C, Nakano-Tateno T, Satou M, Chik C, Tateno T. Emerging role of signal transducer and activator of transcription 3 (STAT3) in pituitary adenomas. Endocr J. 2021;68:1143\u201353.","journal-title":"Endocr J"},{"key":"1206_CR8","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1172\/JCI78173","volume":"125","author":"C Zhou","year":"2015","unstructured":"Zhou C, Jiao Y, Wang R, Ren S, Wawrowsky K, Melmed S. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion. J Clin Invest. 2015;125:1692\u2013702.","journal-title":"J Clin Invest"},{"key":"1206_CR9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1210\/jc.2003-031489","volume":"89","author":"Z Qian","year":"2004","unstructured":"Qian Z, Sano T, Asa S, Yamada S, Horiguchi H, Tashiro T, et al. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness. J Clin Endocrinol Metab. 2004;89:1904\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"1206_CR10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/onc.2016.264","volume":"36","author":"R Chen","year":"2017","unstructured":"Chen R, Duan J, Li L, Ma Q, Sun Q, Ma J, et al. mTOR promotes pituitary tumor development through activation of PTTG1. Oncogene. 2017;36:979\u201388.","journal-title":"Oncogene"},{"key":"1206_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17:93\u2013115.","journal-title":"Nat Rev Cancer"},{"key":"1206_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JME-08-0146","volume":"42","author":"V Quereda","year":"2009","unstructured":"Quereda V, Malumbres M. Cell cycle control of pituitary development and disease. J Mol Endocrinol. 2009;42:75\u201386.","journal-title":"J Mol Endocrinol"},{"key":"1206_CR13","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2010-0091","volume":"24","author":"A Roussel-Gervais","year":"2010","unstructured":"Roussel-Gervais A, Bilodeau S, Vallette S, Berthelet F, Lacroix A, Figarella-Branger D. Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. Mol Endocrinol. 2010;24:1835\u201345.","journal-title":"Mol Endocrinol"},{"key":"1206_CR14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/cancers12020308","volume":"12","author":"L Lamb","year":"2020","unstructured":"Lamb L, Sim H, McCormack A. Exploring the role of novel medical therapies for aggressive pituitary tumors: a review of the literature-are we there yet? Cancers (Basel). 2020;12:308.","journal-title":"Cancers (Basel)."},{"key":"1206_CR15","doi-asserted-by":"crossref","first-page":"19373","DOI":"10.1038\/s41598-020-76555-8","volume":"10","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Andonegui-Elguera S, Pe\u00f1a-Mart\u00ednez E, Silva-Rom\u00e1n G, Vela-Pati\u00f1o S, Gomez-Apo E, Chavez-Macias L, Vargas-Ortega G, Espinosa-de-Los-Monteros L, Gonzalez-Virla B, Perez C, et al. Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep. 2020;10:19373.","journal-title":"Sci Rep"},{"key":"1206_CR16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/genes11121422","volume":"11","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Pe\u00f1a-Mart\u00ednez E, Silva-Rom\u00e1n G, Vela-Pati\u00f1o S, Guzman-Ortiz AL, Quezada H, Gomez-Apo E, Chavez-Macias L, Mercado-Medrez S, Vargas-Ortega G, Espinosa-de-Los-Monteros L, Gonzalez-Virla B, Perez C, et al. Proteomic and transcriptomic analysis identify spliceosome as significant component of the molecular machinery in the pituitary tumors derived from POU1F1- and NR5A1- ell lienages. Genes (Basel). 2020;11:1422.","journal-title":"Genes (Basel)"},{"key":"1206_CR17","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cancers11101618","volume":"11","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov A, Slaby O, Ionescu C, Berindan-Neagoe I. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel). 2019;11:1618.","journal-title":"Cancers (Basel)"},{"key":"1206_CR18","doi-asserted-by":"crossref","first-page":"100128","DOI":"10.1016\/j.xcrm.2020.100128","volume":"1","author":"D Essegian","year":"2020","unstructured":"Essegian D, Khurana R, Stathias V, Sch\u00fcrer S. The clinical kinase index: a method to prioritize understudied kinases as drug targets for the treatment of cancer. Cell Rep Med. 2020;1:100128.","journal-title":"Cell Rep Med."},{"key":"1206_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01271-7","author":"T Miwa","year":"2021","unstructured":"Miwa T, Kanda M, Shimizu D, Umeda S, Sawaki K, Tanaka H, Tanaka C, Hattori N, Hayashi M, Yamada N, Nakayama G, Koike M, Kodera Y. Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway. Br J Cancer. 2021. https:\/\/doi.org\/10.1038\/s41416-021-01271-7.","journal-title":"Br J Cancer"},{"key":"1206_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 2017;9:52.","journal-title":"Cancers (Basel)"},{"key":"1206_CR21","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1158\/1078-0432.CCR-12-1451","volume":"19","author":"C Cummings","year":"2013","unstructured":"Cummings C, Deryckere D, Earp H, Graham D. Molecular pathways: MERTK signaling in cancer. Clin Cancer Res. 2013;19:5275\u201380.","journal-title":"Clin Cancer Res"},{"key":"1206_CR22","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/ijms21072581","volume":"21","author":"E Owusu-Obeng","year":"2020","unstructured":"Owusu-Obeng E, Rusciano I, Marvi M, Fazio A, Ratti S, Follo M, Xian J, Manzoli L, Billi A, Mongiorgi S, Ramazzotti G, Cocco L. Phosphoinositide-dependent signaling in cancer: a focus on phospholipase C isozymes. Int J Mol Sci. 2020;21:2581.","journal-title":"Int J Mol Sci"},{"key":"1206_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41388-018-0438-2","volume":"38","author":"M Sarwar","year":"2019","unstructured":"Sarwar M, Syed-Khaja A, Aleskandarany M, Karlsson R, Althobiti M, \u00d8dum N, Mongan N, Dizeyi N, Johnson H, Green A, Ellis I, Rakha E, Persson J. The role of PIP5K1\u03b1\/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1\u03b1 inhibitor. Oncogene. 2019;38:375\u201389.","journal-title":"Oncogene"},{"key":"1206_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/ERC-18-0330","volume":"26","author":"P Xekouki","year":"2019","unstructured":"Xekouki P, Lodge E, Matschke J, Santambrogio A, Apps J, Sharif A, et al. Non-secreting pituitary tumours characterised by enhanced expression of YAP\/TAZ. Endocr Relat Cancer. 2019;26:215\u201325.","journal-title":"Endocr Relat Cancer"},{"key":"1206_CR25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fendo.2015.00188","volume":"6","author":"H Robbins","year":"2016","unstructured":"Robbins H, Hague A. The PI3K\/Akt pathway in tumors of endocrine tissues. Front Endocrinol (Lausanne). 2016;6:188.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1206_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","volume":"17","author":"K Bhullar","year":"2018","unstructured":"Bhullar K, Lagar\u00f3n N, McGowan E, Parmar I, Jha A, Hubbard B, Rupasinghe H. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018;17:48.","journal-title":"Mol Cancer"},{"key":"1206_CR27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrm.2016.27","volume":"17","author":"P Hydbring","year":"2016","unstructured":"Hydbring P, Malumbres M, Sicinski P. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol. 2016;17:280\u201392.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1206_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2018.00444","volume":"9","author":"T Araki","year":"2018","unstructured":"Araki T, Liu N. Cell cycle regulators and lineage-specific therapeutic targets for cushing disease. Front Endocrinol (Lausanne). 2018;9:1\u201310.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1206_CR29","first-page":"7121","volume":"14","author":"S Park","year":"2017","unstructured":"Park S, Jang J, Lee Y, Kim J, Kim K, Kim Y. Function of cell-cycle regulators in predicting silent pituitary adenoma progression following surgical resection. Oncol Lett. 2017;14:7121\u201330.","journal-title":"Oncol Lett"},{"key":"1206_CR30","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210329122147","author":"R Pepino","year":"2021","unstructured":"Pepino R, Coelho F, Janku T, Alencar T, de Azevedo W, Canduri F. Overview of PCTK3\/CDK18: a cyclin-dependent kinase involved in specific functions in post-mitotic cells. Curr Med Chem. 2021. https:\/\/doi.org\/10.2174\/0929867328666210329122147.","journal-title":"Curr Med Chem"},{"key":"1206_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.2000.01088.x","volume":"53","author":"H Turner","year":"2000","unstructured":"Turner H, Nagy Z, Sullivan N, Esiri M, Wass J. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland. Clin Endocrinol (Oxf). 2000;53:337\u201344.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1206_CR32","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/eje.0.143r001","volume":"143","author":"S Jordan","year":"2000","unstructured":"Jordan S, Lidhar K, Korbonits M, Lowe D, Grossman A. Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol. 2000;143:R1-6.","journal-title":"Eur J Endocrinol"},{"key":"1206_CR33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/MCB.01764-06","volume":"27","author":"F Bai","year":"2007","unstructured":"Bai F, Pei X, Nishikawa T, Smith M, Xiong Y. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Mol Cell Biol. 2007;27:1495\u2013504.","journal-title":"Mol Cell Biol"},{"key":"1206_CR34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1098-2264(199904)24:4<328::AID-GCC6>3.0.CO;2-P","volume":"24","author":"D Simpson","year":"1999","unstructured":"Simpson D, Bicknell J, McNicol A, Clayton R, Farrell W. Hypermethylation of the p16\/CDKN2A\/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chromosomes Cancer. 1999;24:328\u201336.","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"1206_CR35","first-page":"648","volume":"2020","author":"R Pivonello","year":"2003","unstructured":"Pivonello R, Ferrigno R, De Martino M, Simeoli C, Di Paola N, Pivonello C, Barba L, Negri M, De Angelis C, Colao A. Medical treatment of cushing\u2019s disease: an overview of the current and recent clinical trials. Front Endocrinol (Lausanne). 2003;2020(11):648.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1206_CR36","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","volume":"112","author":"S Melmed","year":"2003","unstructured":"Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest. 2003;112:1603\u201318.","journal-title":"J Clin Invest."},{"key":"1206_CR37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s40618-020-01275-9","volume":"43","author":"E Guadagno","year":"2020","unstructured":"Guadagno E, D\u2019Avella E, Cappabianca P, Colao A, DelBassoDeCaro M. Ki67 in endocrine neoplasms: to count or not to count, this is the question! A systematic review from the English language literature. J Endocrinol Invest. 2020;43:1429\u201345.","journal-title":"J Endocrinol Invest."},{"key":"1206_CR38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrm.2017.27","volume":"18","author":"F Baralle","year":"2017","unstructured":"Baralle F, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18:437\u201351.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1206_CR39","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/onc.2013.533","volume":"33","author":"S Oltean","year":"2014","unstructured":"Oltean S, Bates D. Hallmarks of alternative splicing in cancer. Oncogene. 2014;33:5311\u20138.","journal-title":"Oncogene"},{"key":"1206_CR40","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1074\/jbc.M708188200","volume":"283","author":"P Loyer","year":"2008","unstructured":"Loyer P, Trembley J, Grenet J, Busson A, Corlu A, Zhao W, Kocak M, Kidd V, Lahti J. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. J Biol Chem. 2008;283:7721\u201332.","journal-title":"J Biol Chem"},{"key":"1206_CR41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcdb.2020.04.016","volume":"107","author":"P Loyer","year":"2020","unstructured":"Loyer P, Trembley J. Roles of CDK\/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression. Semin Cell Dev Biol. 2020;107:36\u201345.","journal-title":"Semin Cell Dev Biol"},{"key":"1206_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-1028-1-15","volume":"1","author":"K Knudsen","year":"2006","unstructured":"Knudsen K. The cyclin D1b splice variant: an old oncogene learns new tricks. Cell Div. 2006;1:1\u201315.","journal-title":"Cell Div"},{"key":"1206_CR43","first-page":"30213","volume":"S0168\u20139525","author":"M Petasny","year":"2020","unstructured":"Petasny M, Bentata M, Pawellek A, Baker M, Kay G, Salton M. Splicing to keep cycling: the importance of pre-mRNA splicing during the cell cycle. Trends Genet. 2020;S0168\u20139525:30213\u20134.","journal-title":"Trends Genet"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-022-01206-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:05:20Z","timestamp":1646726720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-022-01206-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1186\/s12920-022-01206-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742058937.793597882","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participating patients were recruited with signed informed consent and ethical approval from the Comisi\u00f3n Nacional de \u00c9tica e Investigaci\u00f3n Cient\u00edfica del Instituto Mexicano del Seguro Social in accordance with the Helsinki declaration. (R-2019\u2013785-052).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare not having any conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}